Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Catalent, Novo Nordisk and FTC
Consumer groups ask FTC to block Novo Holdings-Catalent deal
U.S. consumer groups and two large labor unions urged the U.S. Federal Trade Commission on Thursday to block Novo Holdings, the controlling shareholder of Novo Nordisk , from acquiring contract drug manufacturer Catalent ,
Consumer, labor groups urge FTC to block Catalent sale to Novo Nordisk - report
Five U.S. consumer groups and two big labor unions are pushing for the Federal Trade Commission to block Novo Nordisk Foundation's planned $16.5 billion acquisition of Catalent (NYSE:CTLT), arguing that a deal would hurt competition in weigh-loss drugs.
FTC Urged to Block Novo Holdings' Catalent Acquisition Amid Competition Concerns
U.S. consumer groups and labor unions are urging the FTC to block Novo Holdings' acquisition of Catalent. They argue it could stifle competition for weight loss drugs and gene therapies, affecting companies like Amgen and Pfizer.
Pressure Mounts on Novo’s $16.5B Catalent Buy Amid FTC Review
Senator Elizabeth Warren told the Federal Trade Commission that the acquisition of contract manufacturer Catalent could increase Novo’s dominance over the hot GLP-1 market, reducing competition and increasing prices.
Novo Holdings' $16.5B Catalent buyout in crosshairs as consumer groups ask FTC to block the deal
Novo Holdings is encountering more resistance as it aims to close its $16.5 billion acquisition of pharma manufacturing giant Catalent by the end of the year. | A dozen consumer groups and trade unions penned a letter to Lina Khan,
US Unions Urge FTC to Block Novo Holdings-Catalent Deal Amid Competition Concerns
Consumer groups and labor unions have asked the FTC to block Novo Holdings' acquisition of Catalent due to competition concerns in the weight loss drug and gene therapy markets. The $16.5 billion deal could impact rivals like Amgen and Pfizer in the GLP-1 drug development field.
Consumer and labor groups urge FTC to block Catalent sale to Novo Holdings
The coalition said in a letter sent to the FTC Thursday that the deal could reduce access to GLP-1s, and harm competition in development of cell and gene therapies.
6d
on MSN
Catalent to sell Somerset oral solids facility
Catalent (NYSE:CTLT) is selling its oral solids development and small-scale manufacturing facility in Somerset, New Jersey to ...
4d
Catalent Stock Flat Following the Sell Agreement With Ardena
CTLT announces an agreement to sell its oral solids development and manufacturing facility in Somerset to Ardena.
FiercePharma
6d
Catalent offloads New Jersey manufacturing plant, HQ to Belgian CDMO Ardena
Awaiting a potential acquisition by Novo Holdings, Catalent is giving its contract manufacturing compatriot a boost as Ardena ...
NJBIZ
4d
Catalent to sell Somerset HQ (updated)
The site also serves as an oral solids development and small-scale manufacturing facility for the pharmaceutical company, ...
6d
Catalent to Sell New Jersey Facility
(Reuters) - Catalent has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New ...
bovnews
1d
What’s Causing Catalent Inc (CTLT) Stock’s 8.67% Jump Over the Last Six Months?
On Friday, Catalent Inc (CTLT) stock saw a modest uptick, ending the day at $60.29 which represents a slight increase of $0.20 or 0.33% from the prior close of $60.09. The stock opened at $60 and ...
3d
Minnesota firm acquires North Carolina lab from Catalent
A life sciences company has sold off part of its business that includes a Morrisville facility with hundreds of workers.
BioSpace
4d
Q3 Earnings Kick Off With J&J, Bluebird in Tough Spot, Novo-Catalent Deal Under Fire, More
J&J beat expectations this week to launch the Q3 earnings season; a study about children treated with bluebird bio’s Skysona ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Novo Holdings
New Jersey
Somerset
Federal Trade Commission
Ardena
Feedback